R&D | June 11, 2026
Evonik unveils probiotic advance in fight against antibiotic resistance
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
The Prayagraj lab is designed to handle both routine and specialised testing
The award places the company in the top 5% globally
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
